Interestingly, abnormal elevated DGAT1 in myeloid cells, especially macrophage, was significantly associated with reduced overall survival in patients with gastric cancer (Fig. 3c), indicated that DGAT1 could modulate the property of some immune cells and influence the prognosis of patients in an indirect way. Here, DGAT1 is linked to gastric cancer.